EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions

Maximus Cf Yeung, Carla Saoud iD, Sarah Chiang, Meera Hameed, Cristina R Antonescu iD

The Journal of Pathology: Clinical Research · 2026-07 · 12 (4)

DOI: 10.1002/2056-4538.70094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 25.05.2026. Verfasst von Maximus Cf Yeung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong. Hauptthemen laut MEDLINE: Sarcoma, Receptor, Fibroblast Growth Factor, Type 1, Biomarkers, Tumor, Soft Tissue Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Kristen Ann Carr Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent fusions involving FGFR1‐4 genes have been previously described in rare subsets of mostly benign chondroid and mesenchymal neoplasms involving bone and soft tissue. However, a more comprehensive analysis of sarcomas associated with FGFR fusions, including their incidence and histotypes, has not been performed. Triggered by an FGFR1 ‐rearranged unclassified high‐grade sarcoma with myogenic differentiation, we investigated our molecular database for sarcomas with FGFR gene fusions to assess their recurrent potential and morphologic spectrum. A total of six unclassified sarcomas were identified, occurring in five females and one male, with a median age of 66.5 years. Tumors were located in the uterus and retroperitoneal/trunk soft tissue. Histologically, all tumors were high grade, composed predominantly of spindle cell morphology with variable cytologic atypia, high mitotic activity, and areas of necrosis. By immunohistochemistry, all tumors demonstrated evidence of myogenic differentiation, with focal or diffuse positivity for one or more markers (desmin, h‐caldesmon, smooth muscle actin). However, none of the cases displayed diagnostic features of leiomyosarcoma or other known pathologic entities. Molecular studies revealed recurrent fusions involving FGFR1 ( n = 3), FGFR2 ( n = 1), and FGFR4 ( n = 2), retaining the kinase domain. Additional recurrent genomic alterations included TP53 mutations, CDKN2A homozygous deletions, and RB1 alterations. Most patients followed an aggressive clinical course, including metastases and disease‐related mortality. These findings expand the spectrum of sarcomas driven by FGFR gene fusions, underscoring the importance of molecular testing for accurate diagnosis and potential targeted therapy in high‐grade sarcomas with myogenic features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaReceptor, Fibroblast Growth Factor, Type 1Biomarkers, TumorSoft Tissue NeoplasmsReceptor, Fibroblast Growth Factor, Type 4HumansFemaleMaleAgedMiddle AgedCell DifferentiationGene FusionImmunohistochemistryNeoplasm Grading

Stichwörter der Autor:innen

FGFRfusionmyogenicsarcoma

Substanzen

Receptor, Fibroblast Growth Factor, Type 1Biomarkers, TumorReceptor, Fibroblast Growth Factor, Type 4FGFR1 protein, humanFGFR4 protein, human

Autor:innen und Institutionen

  • Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Carla Saoud, Cristina R Antonescu

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Kristen Ann Carr Fund
  • Cycle for Survival
  • National Institutes of Health

Zitieren

APA

Yeung, M. C., Saoud, C., Chiang, S., Hameed, M., & Antonescu, C. R. (2026). A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions. The Journal of Pathology: Clinical Research, 12(4). https://doi.org/10.1002/2056-4538.70094

Vancouver

Yeung MC, Saoud C, Chiang S, Hameed M, Antonescu CR. A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions. The Journal of Pathology: Clinical Research. 2026;12(4). doi:10.1002/2056-4538.70094

BibTeX
@article{Yeung2026,
  author = {Yeung, Maximus Cf and Saoud, Carla and Chiang, Sarah and Hameed, Meera and Antonescu, Cristina R},
  title = {A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1002/2056-4538.70094}
}
Kostenlos starten →